WRF Venture Analysts

Kendan Jones-Isaac

WRF Venture Analyst

Kendan Jones-Isaac

WRF Venture Analyst

Kendan is a native of Washington State and earned his B.S. in Cellular, Molecular & Developmental Biology in 2005 from the University of Washington and his master’s from the Department of Pharmaceutics (DoP) in 2013.

He returned to the DoP in 2018 and is currently a PhD candidate in Dr. Edward Kelly’s lab. Kendan’s thesis project centers on developing a 3D, microphysiological model of kidney stone disease.

Maneeshika Madduri

WRF Venture Analyst

Maneeshika Madduri

WRF Venture Analyst

Maneeshika is a PhD candidate at the University of Washington in Seattle, WA, being advised by Dr. Amy Orsborn and Dr. Sam Burden. Her research is at the intersection of neuroscience and electrical engineering, using control systems, game theory and brain-machine interfaces to explore the learning dynamics between humans and machines.

Maneeshika completed her BS in electrical engineering in 2013 and MS in electrical engineering in 2015, both from Stanford University. Maneeshika was awarded a Fulbright Research Grant in 2013 to research solar energy systems in Kathmandu, Nepal. Her engineering experience includes working as a computer engineering at Sandia National Laboratories in Albuquerque, New Mexico and as an embedded systems engineer at Cala Health, a neurotechnology start-up in Burlingame, CA.

Deeter Neumann, Pharm.D.

WRF Venture Analyst

Deeter Neumann, Pharm.D.

WRF Venture Analyst

Deeter Neumann is a board certified oncology pharmacist, and is currently pursuing a Masters of biomedical regulatory affairs at the University of Washington. Deeter is hoping to pair his clinical experience with regulatory knowledge in order to work as part of a team toward bringing innovative cancer therapeutics to market.

Deeter earned his BS in genetics from the University of Wisconsin – Madison, followed by his Doctor of Pharmacy (PharmD) from the University of Minnesota College of Pharmacy. Following the completion of his PharmD, Deeter completed a year of pharmacy residency training at Michigan Medicine (University of Michigan) and a year of oncology pharmacy training at UW Medicine/Seattle Cancer Care Alliance.

Heidi Spears

WRF Venture Analyst

Heidi Spears

WRF Venture Analyst

Ms. Spears is a venture analyst with expertise in fundamental biophysics, quantitative fluorescence microscopy, synthetic biology, and manufacturing. She is a Ph.D. candidate in UW’s Department of Chemistry and is investigating the physical nature of how proteins sense cell membranes.

Ms. Spears received her M.S. in biomedical engineering from the University of Utah and a B.S. in chemical engineering from Colorado State University. Outside of WRF and research, she serves as a liaison for UW in the High School, a program which helps Washington state high school students earn college credit.